Engineering bacterium capable of controllably producing mono-rhamnolipid and di-rhamnolipid as well as construction method and application of engineering bacterium
By knocking out the rhlC gene and building a recombinant expression vector, the fermentation conditions are optimized, and the problem of low production efficiency and purity of rhamnolipid in the existing technology is solved, and efficient and stable production and purity improvement is achieved. It is suitable for multiple fields. application.
Patent Information
- Application Number
- CN202411412581.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-11
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art is difficult to meet the growing demand for rhamnoli lipids, and the yield and purity are affected by a variety of factors, making it difficult to achieve efficient and stable production.
Design an engineered bacteria that can control the production of single and double rhamnolipids. By knocking out the rhlC gene and building a recombinant expression vector, fermentation and culture conditions are optimized, and the proportion of rhamnolipids and yield is increased.
It has achieved efficient and stable rhamnolipid production, with a yield better than wild-type host bacteria. It further improves yield and purity through optimizing the fermentation process, simplifying production steps, and is suitable for applications in different fields.
Smart Images

Figure CN118909906A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of genetic engineering, and relates to an engineering bacterium capable of controllably producing mono- and di-rhamnolipids, and a construction method and application thereof. Background Art
[0002] Rhamnolipid is a biosurfactant with a wide range of biological activities and has great application potential in the fields of oil extraction, environmental remediation, cosmetics, medicine, etc. At present, the production of rhamnolipid is mainly achieved by microbial fermentation, but the yield and purity are affected by many factors, which makes it difficult to meet the growing demand. Therefore, it is of great significance to develop an efficient and stable rhamnolipid production strain.
[0003] Rhamnolipids are homologs with diverse chemical structures, consisting of 1-2 hydrophilic rhamnose molecules and 1-2 hydrophobic saturated or unsaturated fatty acid long chains (C8-C16) connected by β-glycosidic bonds. In Pseudomonas, rhamnosyltransferase I (RhlB) catalyzes the reaction of R-3-hydroxyfattyacids (HAAs) with dTDP-l-rhamnose to synthesize mono-rhamnolipids (mono-RLs), which are then condensed with another molecule of dTDP-l-rhamnose by rhamnosyltransferase II (RhlC) to form di-rhamnolipids (di-RLs). By controlling specific enzymes, the synthesis of a single rhamnolipid can be achieved. For example, some studies have reported that PCR primers were designed based on the rhlC gene sequence of Pseudomonas aeruginosa. After purification, the PCR product was cloned into the pMD series T simple vector to construct pMD-rhlC. The internal sequence of the rhlC gene was digested by restriction enzymes to construct a plasmid pMD-∆rhlC with a target gene internal sequence deleted. The ∆rhlC fragment was inserted into the plasmid pK18mobSacB by double restriction enzyme digestion to construct a targeting plasmid pK18-∆rhlC, which was introduced into Pseudomonas aeruginosa. After screening pressure, secondary homologous recombination occurred to obtain a Pseudomonas aeruginosa knockout strain with the rhlC gene knocked out. The knockout strain was fermented to verify the production of a single rhamnolipid.
[0004] Different Pseudomonas can produce mixtures of mono- and di-rhamnolipids in different proportions, and their physicochemical properties are affected by the proportion of homologues, which in turn affects their application effects. Therefore, the development of engineered bacteria that can efficiently produce rhamnolipids and control the ratio of mono- and di-rhamnolipids is of great significance for the research and application of rhamnolipids. Summary of the invention
[0005] In view of the deficiencies of the prior art and actual needs, the present invention provides an engineering bacterium for controllably producing mono- and di-rhamnolipids, and a construction method and application thereof.
[0006] The present invention adopts the following technical solutions:
[0007] In a first aspect, the present invention provides an engineered bacterium for controllably producing mono- and di-rhamnolipids, wherein the engineered bacterium comprises a Pseudomonas lacking an rhlC gene, and the engineered bacterium further comprises a recombinant expression vector, or a recombinant fragment is integrated into the genome; the recombinant expression vector and the recombinant fragment each independently contain the rhlC gene, and the promoter of the rhlC gene is an inducible promoter.
[0008] It can be understood that the present invention is based on the genetic modification strategy designed for Pseudomonas, and theoretically, all Pseudomonas having the rhlC gene are suitable for the present invention.
[0009] Preferably, the Pseudomonas includes any one of Pseudomonas fluorescens, Pseudomonas aeruginosa or Pseudomonas putica.
[0010] Preferably, Pseudomonas aeruginosa can be purchased from China Industrial Microorganism Culture Collection Administration Center, No.: CICC10351, Pseudomonas fluorescens can be purchased from China Industrial Microorganism Culture Collection Administration Center, No.: CICC 23246, and Pseudomonas putida can be purchased from China Industrial Microorganism Culture Collection Administration Center, No.: CICC 21906.
[0011] Preferably, the inducible promoter comprises an arabinose inducible promoter.
[0012] Preferably, the starting vector of the recombinant expression vector includes any one of pHERD20T vector, pRK2013 vector or pK18Gm vector.
[0013] In a second aspect, the present invention provides a method for constructing an engineering bacterium capable of controllably producing mono- and di-rhamnolipids, the method comprising:
[0014] Take Pseudomonas, knock out its rhlC gene, and introduce a recombinant expression vector into it, or integrate a recombinant fragment into its genome; the recombinant expression vector and the recombinant fragment each independently contain the rhlC gene, and the promoter of the rhlC gene is an inducible promoter.
[0015] It is understandable that the common gene knockout and recombinant expression vector construction methods in the art are applicable to the present invention as long as the genetic modification strategy of the present invention can be achieved.
[0016] Preferably, the knockout method specifically comprises:
[0017] The genome of Pseudomonas was used as a template to amplify the upstream and downstream fragments of the rhlC gene, which were recovered and purified and then double-digested with BamH I / Xho I and Xho I / Hind III, respectively. After recovery and purification, the fragments were connected with the pK18Gm vector recovered by double-digestion with BamH I / Hind III to obtain the suicide plasmid pKrhlCGm, and triparental binding was performed using Pseudomonas, a helper plasmid pRK2013 and the suicide plasmid pKrhlCGm.
[0018] Preferably, the method for constructing the recombinant expression vector specifically includes:
[0019] The rhlC gene was amplified using the genome of Pseudomonas as a template, and after being recovered and purified, it was double-digested with EcoR I / Hind Ⅲ and ligated with pHERD20T plasmid to obtain a recombinant expression vector.
[0020] In a third aspect, the present invention provides the use of the engineered bacteria capable of controllably producing mono- and di-rhamnolipids in the production of rhamnolipids.
[0021] In a fourth aspect, the present invention provides a method for producing rhamnolipid, the method comprising:
[0022] The engineered bacteria capable of controllably producing mono- and di-rhamnolipids are fermented and cultured, and the products are purified to obtain rhamnolipids.
[0023] It is understood that the purification methods of rhamnolipids commonly used in the art are applicable to the present invention.
[0024] Preferably, the culture medium for the fermentation culture contains, by mass percentage, 2%~7% glycerol, 1%~3% yeast powder, 1.0%~4% peptone, 0.2%~1% NaNO3, 0.1%~0.8% KH2PO4, 0.2%~1.0% Na2HPO4·12H2O, 0.2%~2% MgSO4·7H2O, 0.5%~1.5% CaCl2·2H2O, 0.5%~0.8% FeSO4, 0.2%~1.4% CoCl2, and the remainder is water.
[0025] Preferably, the fermentation culture temperature is 25-38°C (for example, it can be 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36 or 37°C), and the pH is 6.2-7.2 (for example, it can be 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 7 or 7.1, etc.).
[0026] Preferably, the fermentation culture further includes an induction step, specifically including adding 0.1 wt % to 0.25 wt % arabinose (for example, 0.12 wt %, 0.15 wt %, 0.18 wt %, 0.2 wt %, 0.22 wt % or 0.24%, etc.) for induction during the fermentation culture for 8 to 12 h (for example, 8.5, 9, 9.5, 10, 10.5, 11 or 11.5 h, etc.).
[0027] In the present invention, the fermentation culture process is optimized and designed, which can further improve the yield and purity of rhamnolipid.
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] The invention designs a completely new genetic modification strategy, wherein the rhamnolipid production strain lacks the rhlC gene, and a complementation strategy is designed at the same time, so that the constructed engineering bacteria can produce mono-rhamnolipid and di-rhamnolipid in different proportions, and the yield of rhamnolipid is also better than that of wild-type host bacteria. In addition, by optimizing the fermentation culture process, the yield and purity of rhamnolipid can be further improved. The method is simple to operate, has high efficiency, does not require the use of antibiotics, can be widely used in the production of rhamnolipid, and can explore the optimal ratio of mono-rhamnolipid and di-rhamnolipid to highlight a certain characteristic of rhamnolipid, so that it can be more effectively applied to different fields, can better reflect the influence of mono-rhamnolipid and di-rhamnolipid on surface performance, eliminate the influence of strains, and simplify the production steps, so that it has selectivity in actual use, which is conducive to promoting the wide application of rhamnolipid. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is the result of thin layer spot density analysis to identify the ratio of mono- and di-rhamnolipids. DETAILED DESCRIPTION
[0031] The technical solution of the present invention is further described below in conjunction with the accompanying drawings and through specific implementation methods. However, the following embodiments are merely examples of the present invention and do not represent or limit the protection scope of the present invention.
[0032] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0033] The extraction method of rhamnolipid in the specific embodiment of the present invention is as follows: first, 15 mL of fermentation broth is poured into a 50 mL centrifuge tube and centrifuged at 10000 r / min for 10 min; 10 mL of supernatant is taken, and the pH is adjusted to about 2.0 with 6 mol / L HCl for acidification, and then an equal volume of ethyl acetate is added, and the mixture is vortexed for 15 to 20 min and then centrifuged at 8000 r / min for 10 min; the organic phase is aspirated, and 8 mL of ethyl acetate is added again for extraction, the organic phases extracted twice are combined, and the rhamnolipid sample is obtained after the organic phase is volatilized.
[0034] Determination of rhamnolipid concentration: First, prepare a rhamnolipid standard curve. Dilute the rhamnolipid standard to 0.1 g / L, 0.2 g / L, 0.5 g / L, and 1 g / L, and measure its absorbance at a wavelength of 620 nm. Use concentration as the horizontal axis and absorbance as the vertical axis to fit the standard curve. y=0.9044x+0.0913, R 2 >0.99.
[0035] Then measure the sample: centrifuge the fermentation broth at 10℃ and 4000 rpm for 20 min to precipitate the bacteria, take the supernatant after centrifugation and dilute it a certain multiple; then take 1 mL of the dilution and add it to the test tube, put the test tube into ice water, slowly drip 4 mL of 0.2% anthrone reagent along the wall of the test tube, and shake it continuously to mix it evenly; then immerse the test tube in a boiling water bath and heat it for 15 min, take it out and immediately cool it with cold water to terminate the reaction, and place it at room temperature for 20 min; finally, use an ultraviolet spectrophotometer to measure the absorbance of the series of rhamnose solutions at a wavelength of 620 nm. Use the uninoculated fermentation medium as a blank control to measure the absorbance of the diluted supernatant; finally, substitute the measured absorbance into the rhamnolipid standard curve equation to obtain the rhamnolipid content.
[0036] Calculation of rhamnolipid purity: rhamnolipid concentration × volume / total weight of precipitate.
[0037] Mono- and di-rhamnolipid detection methods:
[0038] 1. Extraction of glycolipids: The microbial liquid culture was sterilized by centrifugation at 5000 r / min, the supernatant was acidified to adjust the pH to 2, extracted with ether for 3 times, the ether was combined, and washed with water for 3 times, the ether was evaporated to remove the ether, and the residue was the experimental sample.
[0039] 2. Thin layer separation of glycolipids: Prepare glycolipid samples into ethyl acetate solution, spot on thin layer silica gel (HSGF-254), and develop with chloroform / methanol / acetic acid (65 / 15 / 2, V / V / V). Heat with Molish reagent (naphthol / sulfuric acid / ethanol / water, 10.5 / 6.5 / 40.5 / 4.5, m / V / V / V) for color development. Cover the silica gel plate with plastic wrap and scan and record the separation and color development results with a scanner.
[0040] 3. Thin layer spot density analysis: Analyze the scanned image with spot density analysis software. Open the software and open the TLC image with the software. The image will be converted to black and white. Set the spot to black and set the sampling circle to a circular shape. Adjust it to an appropriate size. According to the number and arrangement of the spots on the thin layer, establish the number of columns and rows of the spots. Move the sampling ring to frame the spots on the thin layer chromatography. After all the analysis spots are in the sampling circle, confirm the analysis and obtain the density, area, background density, background area and net density of the target spot. Calculate and analyze. Take the average of the two results.
[0041] Primers used for construction and verification of rhlC gene deletion mutants and complementation strains:
[0042] rhlCup-F: ACGTGGATCCGAGAAGTTTCACTGGAGC (SEQ ID NO. 1);
[0043] rhlCup-R: AGCTCTCGAGTTCGCCAAGGTGTTCCA (SEQ ID NO. 2);
[0044] rhlCdown-F: AGCTCTCGAGTCGGCGAAACGCATT (SEQ ID NO.3);
[0045] rhlCdown-R:ACGTAAGCTTCGCCAACTGATGGAAATG (SEQ ID NO.4);
[0046] pHERD_rhlC-F: ATCTGATAAGAATTCATGGACCGGATAGACAT (SEQ ID NO.5);
[0047] pHERD_rhlC-R: GCCAGTGCCAAGCTTCGATTCGTTCTACTTCCTCG (SEQ ID NO. 6);
[0048] minirhlC-F: GGAATTCATCATGGACCGGATAGAC (SEQ ID NO. 7);
[0049] minirhlC-R:CCCCGGGTCGCCGACTAGGCCTTGG (SEQ ID NO.8);
[0050] minirhlC-F and minirhlC-R are designed primers for the rhlC gene and the sequences on both sides. Their function is to enable DNA polymerase to connect deoxynucleotides from the 3' end of the primers. The genome of strain PAO1 is used as a template to PCR amplify the rhlC gene fragment.
[0051] attB2: GTCGCCGCCGGCGATGC (SEQ ID NO.9);
[0052] CTX1:CCTCGTTCCCAGTTTGTTCC (SEQ ID NO.10);
[0053] attB4: CGCCCTATAGTGAGTCG (SEQ ID NO.11);
[0054] attB5: CGCCCCAACCTCGCTGG (SEQ ID NO. 12).
[0055] The rhlC gene was integrated into the attB site of the rhlC deletion mutant genome, and the obtained strain avoided the use of antibiotics and was more suitable for actual production. PCR verification was performed using detection primers (attB2 and CTX1; attB4 and attB5), and the plasmid was verified to be integrated into the attB site of the Pseudomonas aeruginosa chromosome based on the fragment size.
[0056] Example 1
[0057] In this example, a high-yield rhamnolipid engineering bacterium was constructed and a production test was performed.
[0058] 1. Using the genome of Pseudomonas fluorescens (purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 23246) as a template, rhlCup-F, rhlCup-R and rhlCdown-F, rhlCdown-R were used as primers to amplify the upstream and downstream fragments of the rhlC gene.
[0059] 2. After recovery and purification, double enzyme digestion was performed with BamH I / Xho I and Xho I / Hind III respectively. After recovery and purification, it was ligated with the pK18Gm vector recovered by double enzyme digestion with BamH I / Hind III and transformed into E. coli DH5α.
[0060] 3. The suicide plasmid pKrhlCGm was obtained by colony PCR verification and sequencing analysis.
[0061] 4. Triparental conjugation was performed using Pseudomonas fluorescens, helper plasmid pRK2013 and suicide plasmid pKrhlCGm.
[0062] 5. The rhlC gene was knocked out in the fluorescing Pseudomonas strain through two homologous recombination to obtain the rhlC gene knockout strain.
[0063] 6. A single exchange mutant was obtained on the PIA+LB+Gmr screening plate, and then reversely screened on a 20% sucrose plate to obtain a double exchange mutant without resistance. The rhlC gene knockout strain was obtained by PCR verification.
[0064] 7. Construct the PBAD-rhlC gene expression vector.
[0065] 8. Using the genome of Pseudomonas fluorescens strain as template and pHERD_rhlC-F and pHERD_rhlC-R as primers, PCR amplified the DNA fragment containing the complete rhlC gene.
[0066] 9. After the fragment was recovered and purified, it was double-digested with EcoR I / Hind III with pHERD20T plasmid, ligated, and transformed into E. coli DH5α to obtain the overexpression vector prhlC.
[0067] 10. After the rhlC gene was cloned into the PBAD promoter of the pHERD20T plasmid, the expression of the rhlC gene in the plasmid was induced by arabinose.
[0068] 11. Use 200 mmol / L MgCl2 to prepare competent cells of the rhlC gene knockout strain of Pseudomonas fluorescens.
[0069] 12. The PBAD-rhlC gene overexpression vector prhlC was transferred into the competent cells of the knockout strain by heat shock transformation, so as to induce the rhlC gene in the induced strain by plasmid expression.
[0070] 13. Optimize the culture medium formula, induction method and time.
[0071] 14. Weigh the culture medium. The culture medium formula is (by mass percentage): glycerol 2%, yeast powder 1%, peptone 1.0%, NaNO3 0.2%, KH2PO4 0.1%, Na2HPO4·12H2O 0.2%, MgSO4·7H2O 0.2%, CaCl2·2H2O0.5%, FeSO4 0.5%, CoCl2 0.2%, and the balance is water.
[0072] 15. Sterilize the culture medium at 115°C for 20 min and cool to room temperature before use.
[0073] 16. Take the fluorescent Pseudomonas that has undergone gene knockout and complementation and inoculate it into the culture medium for fermentation and amplification culture.
[0074] 17. The inoculation amount is 3%, the fermentation temperature is 31°C, and the fermentation control pH is 6.7.
[0075] 18. After 10 h of growth, induce the cells by adding arabinose at a concentration of 0.18%.
[0076] 19. Check the concentration of rhamnolipids in the fermentation broth every hour. If it does not increase for three consecutive hours, stop the fermentation. At the same time, culture wild fluorescent Pseudomonas under the same conditions as a control.
[0077] The maximum concentration of rhamnolipid fermented by Pseudomonas fluorescens after gene knockout and complementation was 98 g / L, and the yield was 2.2 g / L / h.
[0078] The ratio of mono-rhamnolipids to di-rhamnolipids was identified by thin layer separation of glycolipids. Glycolipid samples were extracted from the culture medium, developed on a thin layer silica gel plate, soaked in sulfuric acid for a few seconds, and heated at 90°C for 20 min to develop color. This method only develops color for sugars, and the results are shown in Figure 1 . Figure 1 There are two main color spots in the sample, corresponding to the two main glycolipid components. According to the composition and structure analysis of glycolipids, the upper sample has a large mobility and weak relative polarity, which is a monosaccharide glycolipid; the lower sample has a small mobility and strong relative polarity, which is a disaccharide glycolipid. The density of these two spots was analyzed using GISIDdot spot analysis software. The results are shown in Table 1. The ratio of mono- and di-rhamnolipids is 77:23.
[0079] Table 1
[0080]
[0081] Example 2
[0082] In this example, a high-yield rhamnolipid engineering bacterium was constructed and a production test was performed.
[0083] Fermentation was performed by referring to the steps basically the same as those in Example 1, except that in steps 1, 4, 5, and 8, Pseudomonas fluorescens was replaced with Pseudomonas putica (Pseudomonas putica, purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 21906), and Pseudomonas putica with gene knockout and complementation was obtained by induction. The maximum concentration of fermented rhamnolipid was 88 g / L, the yield was 2.09 g / L / h, and the ratio of mono-rhamnolipid to di-rhamnolipid was 80:23.
[0084] Example 3
[0085] In this example, a high-yield rhamnolipid engineering bacterium was constructed and a production test was performed.
[0086] Fermentation was performed by referring to the steps basically the same as those in Example 1, except that in steps 1, 4, 5, and 8, Pseudomonas fluorescens was replaced with Pseudomonas aeruginosa (Pseudomonas aeruginosa, purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 10351), and Pseudomonas aeruginosa with gene knockout and complementation was obtained by induction. The maximum concentration of fermented rhamnolipid was 92 g / L, the yield was 2.12 g / L / h, and the ratio of mono- and di-rhamnolipid was 88:23.
[0087] Example 4
[0088] In this example, a high-yield rhamnolipid engineering bacterium was constructed and a production test was performed.
[0089] The only difference compared with Example 1 is that the culture medium formula in step 14 is: glycerol 1%, NaNO3 1.5%, KH2PO4 5%, Na2HPO4·12H2O 3%, MgSO4 0.8%, CaCl2·2H2O 0.8%, and the balance is water.
[0090] This culture medium was used for fermentation to induce Pseudomonas aeruginosa that had undergone gene knockout and complementation. The maximum concentration of fermented rhamnolipids was 81 g / L, the yield was 1.68 g / L / h, and the ratio of mono- and di-rhamnolipids was 78:23.
[0091] Example 5
[0092] In this example, a high-yield rhamnolipid engineering bacterium was constructed and a production test was performed.
[0093] The only difference compared with Example 1 is that different induction modes and times are tested in step 18, the arabinose concentration is kept constant, and the induction is tested at 8 h, 12 h, 14 h, and 16 h respectively; in addition, the induction start time is kept constant, and the induction concentrations of arabinose are tested at 0.05%, 0.1%, 0.25%, and 0.35 respectively. The results are shown in Table 2. It can be seen from Table 2 that the present invention designs a specific induction time and inducer concentration, which can further increase the yield of rhamnolipid.
[0094] Table 2
[0095]
[0096] Example 6
[0097] In this example, a high-yield rhamnolipid engineering bacterium was constructed and a production test was performed.
[0098] The only difference from Example 1 is that different culture temperatures and pH values are tested in step 17. The fermentation pH is kept constant, and the rhamnolipid production is tested at 22°C, 30°C, 38°C, and 40°C; in addition, the fermentation temperature is kept constant, and the rhamnolipid production is tested at pH values of 6, 6.6, 7.2, and 7.4.
[0099] The results are shown in Table 3, which shows that the control of specific culture pH and temperature in the present invention can further increase the yield of rhamnolipid.
[0100] Table 3
[0101]
[0102] Example 7
[0103] This example analyzes the properties of the optimal ratio of mono- and di-rhamnolipids.
[0104] The effects of different ratios of mono- and di-rhamnolipids are shown in Table 4.
[0105] Table 4
[0106]
[0107] (1) Surface tension and interfacial tension: Rhamnolipids are usually larger and more complex than synthetic surfactants in chemical structure and have more active groups. They can be better adsorbed on the oil-water interface and improve the properties of the oil-water interface. They are therefore more effective in reducing water-air and oil-water interfacial tension.
[0108] (2) Temperature resistance: It can still maintain its surface activity at a high temperature of 90°C.
[0109] (3) Salt resistance: Rhamnolipids do not settle or precipitate in 10% salt solution, while chemical synthetic surfactants will be inactivated in 2-3% salt solution.
[0110] (4) Degradability: Environmentally friendly and degradable.
[0111] Comparative Example 1
[0112] 1. Pseudomonas fluorescens (purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 23246) was used as the fermentation strain.
[0113] 2. Weigh the culture medium. The culture medium formula is (by mass percentage): glycerol 2%, yeast powder 1%, peptone 1.0%, NaNO3 0.2%, KH2PO4 0.1%, Na2HPO4·12H2O 0.2%, MgSO4·7H2O 0.2%, CaCl2·2H2O0.5%, FeSO4 0.5%, CoCl2 0.2%, and the balance is water.
[0114] 3. Sterilize the culture medium at 115°C for 20 min and use after cooling to room temperature.
[0115] 4. The inoculation amount is 3%, the fermentation temperature is 31°C, and the fermentation control pH is 6.7.
[0116] 5. After 10 h of growth, induce the cells by adding arabinose at a concentration of 0.18%.
[0117] 6. Check the concentration of rhamnolipids in the fermentation broth every hour. If it does not increase for three consecutive hours, stop the fermentation.
[0118] 7. The maximum concentration of rhamnolipid fermented by wild Pseudomonas fluorescens was 46 g / L, the yield was 0.92 g / L / h, and the ratio of mono-rhamnolipid to di-rhamnolipid was 45:23. It can be seen that the yield of rhamnolipid produced by wild Pseudomonas fluorescens was significantly lower than that of the engineered bacteria of the present invention.
[0119] Comparative Example 2
[0120] The fermentation was carried out by referring to the steps basically the same as those in Comparative Example 1, except that in step 1, Pseudomonas fluorescens was replaced by Pseudomonas putica (Pseudomonas putica, purchased from China Industrial Microbiological Culture Collection Management Center, No.: CICC 21906), the maximum concentration of rhamnolipid fermented by the original wild Pseudomonas putica was 38 g / L, the yield was 0.88 g / L / h, and the ratio of mono-rhamnolipid to di-rhamnolipid was 50:23. It can be seen that the yield of rhamnolipid of wild Pseudomonas putica was significantly lower than that of the engineered bacteria of the present invention.
[0121] Comparative Example 3
[0122] The fermentation was carried out by referring to the steps basically the same as those in Comparative Example 1, except that in step 1, Pseudomonas fluorescens was replaced with Pseudomonas aeruginosa (Pseudomonas aeruginosa, purchased from China Industrial Microbiological Culture Collection Management Center, No.: CICC 10351), the maximum concentration of rhamnolipid fermented by the original wild Pseudomonas aeruginosa was 42 g / L, the yield was 0.84 g / L / h, and the ratio of mono- and di-rhamnolipids was 45:23. It can be seen that the yield of rhamnolipids from wild Pseudomonas aeruginosa is significantly lower than that of the engineered bacteria of the present invention.
[0123] In summary, the rhamnolipid production strain of the present invention lacks the rhlC gene, and a complementation strategy is designed. The constructed engineered bacteria can produce single and double rhamnolipids in different ratios, and the yield of rhamnolipids is also better than that of the wild-type host bacteria. In addition, by optimizing the fermentation culture process, the yield and purity of rhamnolipids can be further improved. The fermentation concentration of rhamnolipids is 88-98 g / L, the yield is 2.09-2.2 g / L / h, and the ratio of single and double rhamnolipids is (77-88):23. The method is simple to operate and has high efficiency. No antibiotics are required. It can be widely used in the production of rhamnolipids. The optimal ratio of single and double rhamnolipids can also be explored to highlight a certain characteristic of rhamnolipids, so that it can be more effectively applied to different fields. It can also better reflect the influence of single and double rhamnolipids on surface properties, eliminate the influence of strains, and simplify the production steps, so that it has selectivity in actual use, which is conducive to promoting the wide application of rhamnolipids.
[0124] The above description is only a preferred embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions easily made within the technical scope disclosed in the present invention are within the protection scope of the present invention.
Claims
1. An engineered bacterium capable of controlling the production of mono- and di-rhamnolipids, It is characterized in that The engineered bacteria include Pseudomonas lacking the rhlC gene, and the engineered bacteria also contain a recombinant expression vector, or a recombinant fragment is integrated into the genome; The recombinant expression vector and the recombinant fragment each independently contain the rhlC gene, and the promoter of the rhlC gene is an inducible promoter.
2. The engineered bacteria capable of controlling the production of mono- and di-rhamnolipids according to claim 1, It is characterized in that The Pseudomonas includes any one of Pseudomonas fluorescens, Pseudomonas aeruginosa or Pseudomonas putida.
3. The engineered bacteria capable of controlling the production of mono- and di-rhamnolipids according to claim 1, It is characterized in that The inducible promoter includes an arabinose inducible promoter.
4. The engineered bacteria capable of controlling the production of mono- and di-rhamnolipids according to claim 1, It is characterized in that The starting vector of the recombinant expression vector includes any one of pHERD20T vector, pRK2013 vector or pK18Gm vector.
5. A method for constructing an engineering bacterium capable of controllably producing mono- and di-rhamnolipids as claimed in claim 1, It is characterized in that The construction method comprises: Take Pseudomonas, knock out its rhlC gene, and introduce a recombinant expression vector into it, or integrate the recombinant fragment into its genome; The recombinant expression vector and the recombinant fragment each independently contain the rhlC gene, and the promoter of the rhlC gene is an inducible promoter.
6. The method for constructing an engineering bacterium capable of controllably producing mono- and di-rhamnolipids according to claim 5, It is characterized in that The knockout method specifically includes: The genome of Pseudomonas was used as a template to amplify the upstream and downstream fragments of the rhlC gene, which were recovered and purified and then double-digested with BamHI / Xho I and Xho I / Hind III, respectively. After recovery and purification, the fragments were connected with the pK18Gm vector recovered by double-digestion with BamHI / Hind III to obtain the suicide plasmid pKrhlCGm, and triparental binding was performed using Pseudomonas, a helper plasmid pRK2013 and the suicide plasmid pKrhlCGm.
7. The method for constructing an engineering bacterium capable of controllably producing mono- and di-rhamnolipids according to claim 5, It is characterized in that The method for constructing the recombinant expression vector specifically includes: The rhlC gene was amplified using the genome of Pseudomonas as a template, and after being recovered and purified, it was double-digested with EcoRI / Hind Ⅲ and ligated with pHERD20T plasmid to obtain a recombinant expression vector.
8. Use of the engineered bacteria capable of controllably producing mono- and di-rhamnolipids as claimed in claim 1 in producing rhamnolipids.
9. A method for producing rhamnolipid, It is characterized in that The method comprises: The engineered bacteria capable of controllably producing mono- and di-rhamnolipids according to claim 1 are fermented and cultured, and the product is purified to obtain rhamnolipids.
10. The method for producing rhamnolipid according to claim 9, It is characterized in that The fermentation culture medium contains 2% to 7% glycerol, 1% to 3% yeast powder, 1.0% to 4% peptone, NaNO 3 0.2%~1%, KH 2 PO 4 0.1%~0.8%, Na 2 HPO 4 12H 2 O 0.2%~1.0%, MgSO 4 7H 2 O 0.2%~2%, CaCl 2 ·2H 2 O 0.5%~1.5%, FeSO 4 0.5%~0.8%, CoCl 2 0.2%~1.4%, the balance is water; The fermentation culture temperature is 25-38°C and the pH is 6.2-7.2; The fermentation culture also includes an induction step, specifically including adding 0.1 wt% to 0.25 wt% arabinose for induction during the fermentation culture for 8 to 12 hours.
Citation Information
Patent Citations
Double-rhamnolipid production strain, construction method and application of double-rhamnolipid production strain
CN112941001A
Construction and application of strains for producing single and double rhamnolipids in different proportions
CN118773277A
Cited By
Method for producing single-component rhamnolipid with high yield
CN119913228A
A method for producing a high-yield single-component rhamnolipid
CN119913228B
Synthetic rhamnolipid component controllable engineering strain and application
CN122686542A
An engineered strain with controllable synthesis of rhamnolipid components and its applications
CN122686542B
